Common variants at ten loci influence QT interval duration in the QTGEN Study (original) (raw)

References

1. Straus, S.M. et al. Prolonged QTc interval and risk of sudden cardiac death in a population of older adults. J. Am. Coll. Cardiol. 47, 362–367 (2006).
   Article Google Scholar
2. Newton-Cheh, C. et al. QT interval is a heritable quantitative trait with evidence of linkage to chromosome 3 in a genome-wide linkage analysis: The Framingham Heart Study. Heart Rhythm 2, 277–284 (2005).
   Article Google Scholar
3. Newton-Cheh, C. & Shah, R. Genetic determinants of QT interval variation and sudden cardiac death. Curr. Opin. Genet. Dev. 17, 213–221 (2007).
   Article CAS Google Scholar
4. Splawski, I. et al. Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2. Circulation 102, 1178–1185 (2000).
   Article CAS Google Scholar
5. Arking, D.E. et al. A common genetic variant in the NOS1 regulator NOS1AP modulates cardiac repolarization. Nat. Genet. 38, 644–651 (2006).
   Article CAS Google Scholar
6. Bezzina, C.R. et al. A common polymorphism in KCNH2 (HERG) hastens cardiac repolarization. Cardiovasc. Res. 59, 27–36 (2003).
   Article CAS Google Scholar
7. Pfeufer, A. et al. Common variants in myocardial ion channel genes modify the QT interval in the general population: results from the KORA study. Circ. Res. 96, 693–701 (2005).
   Article CAS Google Scholar
8. Newton-Cheh, C. et al. Common genetic variation in KCNH2 is associated with QT interval duration: The Framingham Heart Study. Circulation 116, 1128–1136 (2007).
   Article CAS Google Scholar
9. Gouas, L. et al. Association of KCNQ1, KCNE1, KCNH2 and SCN5A polymorphisms with QTc interval length in a healthy population. Eur. J. Hum. Genet. 13, 1213–1222 (2005).
   Article CAS Google Scholar
10. Psaty, B.M. et al. Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium: design of prospective meta-analyses of genome-wide association studies from five cohorts. Circulation: Cardiovascular Genetics 2, 73–80 (2009).
    Google Scholar
11. Servin, B. & Stephens, M. Imputation-based analysis of association studies: candidate regions and quantitative traits. PloS Genet. 3, e114 (2007).
    Article Google Scholar
12. Devlin, B. & Roeder, K. Genomic control for association studies. Biometrics 55, 997–1004 (1999).
    Article CAS Google Scholar
13. Pfeufer, A. et al. Common variants in ten loci modulate QT interval duration in the QTSCD study. Nat. Genet. advance online publication, doi:10.1038/ng.362 (22 March 2008).
14. Aarnoudse, A.J. et al. Common NOS1AP variants are associated with a prolonged QTc interval in the Rotterdam Study. Circulation 116, 10–16 (2007).
    Article Google Scholar
15. Lehtinen, A.B. et al. Association of NOS1AP genetic variants with QT interval duration in families from the Diabetes Heart Study. Diabetes 57, 1108–1114 (2008).
    Article CAS Google Scholar
16. Post, W. et al. Associations between genetic variants in the NOS1AP (CAPON) gene and cardiac repolarization in the old order Amish. Hum. Hered. 64, 214–219 (2007).
    Article CAS Google Scholar
17. Tobin, M.D. et al. Gender and effects of a common genetic variant in the NOS1 regulator NOS1AP on cardiac repolarization in 3761 individuals from two independent populations. Int. J. Epidemiol. 37, 1132–1141 (2008).
    Article Google Scholar
18. Eijgelsheim, M. et al. Identification of a common variant at the NOS1AP locus strongly associated to QT-interval duration. Hum. Mol. Genet. 18, 347–357 (2009).
    Article CAS Google Scholar
19. Pietila, E. et al. Association between HERG K897T polymorphism and QT interval in middle-aged Finnish women. J. Am. Coll. Cardiol. 40, 511–514 (2002).
    Article CAS Google Scholar
20. Sotoodehnia, N. et al. KCNE1 Gene D85N Variant, QT Interval, and Risk Of Mortality. Circulation 111, e231 (2005).
    Google Scholar
21. Marjamaa, A. et al. Common candidate gene variants are associated with QT interval duration in the general population. J. Intern. Med. advance online publication, doi:10.1111/j.1365-2796.2008.02026.x (25 October 2008).
22. Wei, J. et al. KCNE1 polymorphism confers risk of drug-induced long QT syndrome by altering kinetic properties of I-Ks potassium channels. Circulation 100, 495–495 (1999).
    Google Scholar
23. Paulussen, A.D. et al. Genetic variations of KCNQ1, KCNH2, SCN5A, KCNE1, and KCNE2 in drug-induced long QT syndrome patients. J. Mol. Med. 82, 182–188 (2004).
    Article CAS Google Scholar
24. Salisbury, B.A. et al. The single nucleotide polymorphism D85N-KCNE1 is associated with both congenital and drug-induced long QT. Heart Rhythm 3(Suppl. 1), S98 (2006).
    Article Google Scholar
25. Splawski, I. et al. Variant of SCN5A sodium channel implicated in risk of cardiac arrhythmia. Science 297, 1333–1336 (2002).
    Article CAS Google Scholar
26. Burke, A. et al. Role of SCN5A Y1102 polymorphism in sudden cardiac death in blacks. Circulation 112, 798–802 (2005).
    Article CAS Google Scholar
27. Amsterdam, A. et al. Identification of 315 genes essential for early zebrafish development. Proc. Natl. Acad. Sci. USA 101, 12792–12797 (2004).
    Article CAS Google Scholar
28. Qu, X. et al. Ndrg4 is required for normal myocyte proliferation during early cardiac development in zebrafish. Dev. Biol. 317, 486–496 (2008).
    Article CAS Google Scholar
29. Milan, D.J. et al. Drugs that induce repolarization abnormalities cause bradycardia in zebrafish. Circulation 107, 1355–1358 (2003).
    Article Google Scholar
30. Luo, W. et al. Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of beta-agonist stimulation. Circ. Res. 75, 401–409 (1994).
    Article CAS Google Scholar
31. Schmitt, J.P. et al. Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban. Science 299, 1410–1413 (2003).
    Article CAS Google Scholar
32. Haghighi, K. et al. A mutation in the human phospholamban gene, deleting arginine 14, results in lethal, hereditary cardiomyopathy. Proc. Natl. Acad. Sci. USA 103, 1388–1393 (2006).
    Article CAS Google Scholar
33. Splawski, I. et al. Severe arrhythmia disorder caused by cardiac L-type calcium channel mutations. Proc. Natl. Acad. Sci. USA 102, 8089–8096 (2005).
    Article CAS Google Scholar
34. Street, V.A. et al. Mutation of a putative protein degradation gene LITAF/SIMPLE in Charcot-Marie-Tooth disease 1C. Neurology 60, 22–26 (2003).
    Article CAS Google Scholar
35. Dawber, T., Kannel, W.B. & Lyell, L.P. An approach to longitudinal studies in a community: the Framingham Heart Study. Ann. NY Acad. Sci. 107, 539–556 (1963).
    Article CAS Google Scholar
36. Kannel, W.B., Feinleib, M. & McNamara, P.M. An investigation of coronary heart disease in families: the Framingham Offspring Study. Am. J. Epidemiol. 110, 281–290 (1979).
    Article CAS Google Scholar
37. Splansky, G.L. et al. The third generation cohort of the National Heart, Lung, and Blood Institute's Framingham Heart Study: design, recruitment, and initial examination. Am. J. Epidemiol. 165, 1328–1335 (2007).
    Article Google Scholar
38. Hofman, A. et al. The Rotterdam Study: objectives and design update. Eur. J. Epidemiol. 22, 819–829 (2007).
    Article Google Scholar
39. Hofman, A., Grobbee, D.E., de Jong, P.T. & van den Ouweland, F.A. Determinants of disease and disability in the elderly: the Rotterdam Elderly Study. Eur. J. Epidemiol. 7, 403–422 (1991).
    Article CAS Google Scholar
40. Fried, L.P. et al. The Cardiovascular Health Study: design and rationale. Ann. Epidemiol. 1, 263–276 (1991).
    Article CAS Google Scholar
41. van Bemmel, J.H., Kors, J.A. & van Herpen, G. Methodology of the modular ECG analysis system MEANS. Methods Inf. Med. 29, 346–353 (1990).
    Article CAS Google Scholar
42. Rabbee, N. & Speed, T.P. A genotype calling algorithm for affymetrix SNP arrays. Bioinformatics 22, 7–12 (2006).
    Article CAS Google Scholar
43. Li, Y. & Mach Abecasis, G.R. 1.0: Rapid haplotype reconstruction and missing genotype inference. Am. J. Hum. Genet. S79, 2290 (2006).
    Google Scholar
44. de Bakker, P.I. et al. Practical aspects of imputation-driven meta-analysis of genome-wide association studies. Hum. Mol. Genet. 17, R122–R128 (2008).
    Article CAS Google Scholar
45. Pe'er, I., Yelensky, R., Altshuler, D. & Daly, M.J. Estimation of the multiple testing burden for genomewide association studies of nearly all common variants. Genet. Epidemiol. 32, 381–385 (2008).
    Article Google Scholar

Download references

Acknowledgements

The Framingham Heart Study work was conducted in part using data and resources from the Framingham Heart Study of the National Heart Lung and Blood Institute of the National Institutes of Health and Boston University School of Medicine (contract #N01-HC-25195) , its contract with Affymetrix for genotyping services (contract #N02-HL-6-4278), and the Doris Duke Charitable Foundation (C.N.-C.) and Burroughs Wellcome Fund (C.N.-C.). The Framingham analyses reflect intellectual input and resource development from the Framingham Heart Study investigators participating in the SNP Health Association Resource (SHARe) project. A portion of this research utilized the Linux Cluster for Genetic Analysis (LinGA-II) funded by the Robert Dawson Evans Endowment of the Department of Medicine at Boston University School of Medicine and Boston Medical Center. The measurement of ECG intervals in Framingham Heart Study generation 1 and 2 samples was done by eResearchTechnology and supported by an unrestricted grant from Pfizer. The measurement of ECG intervals in the Framingham Heart Study generation 3 sample was completed by A. Hirji and S. Kovvali using AMPS software provided through an unrestricted academic license by Analyzing Medical Parameters for Solutions (A.M.P.S., LLC). The Rotterdam Study is funded by Erasmus Medical Center and Erasmus University, Rotterdam, Netherlands Organization for the Health Research and Development (ZonMw), the Research Institute for Diseases in the Elderly (RIDE), the Ministry of Education, Culture and Science, the Ministry for Health, Welfare and Sports, the European Commission (DG XII), and the Municipality of Rotterdam. The generation and management of GWAS genotype data for the Rotterdam Study is supported by the Netherlands Organisation of Scientific Research NWO Investments (#175.010.2005.011, 911-03-012). This study is funded by the Research Institute for Diseases in the Elderly (014-93-015; RIDE2), and the Netherlands Genomics Initiative (NGI)/Netherlands Organisation for Scientific Research (NWO) project #050-060-810. The CHS research reported in this article was supported by contract numbers N01-HC-85079 through N01-HC-85086, N01-HC-35129, N01 HC-15103, N01 HC-55222, N01-HC-75150, N01-HC-45133, grant numbers U01 HL080295 and R01 HL087652 from the National Heart, Lung, and Blood Institute, with additional contribution from the National Institute of Neurological Disorders and Stroke. DNA handling and genotyping was supported in part by National Center for Research Resources grant M01RR00069 to the Cedars-Sinai General Clinical Research Center Genotyping core and National Institute of Diabetes and Digestive and Kidney Diseases grant DK063491 to the Southern California Diabetes Endocrinology Research Center. A full list of principal CHS investigators and institutions can be found at http://www.chs-nhlbi.org/pi.htm. The authors acknowledge the essential role of the CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology) Consortium in development and support of this manuscript. CHARGE members include the Netherland's Rotterdam Study, the NHLBI's Atherosclerosis Risk in Communities (ARIC) Study, Cardiovascular Health Study (CHS) and Framingham Heart Study (FHS), and the NIA's Iceland Age, Gene/Environment Susceptibility (AGES) Study. C.N.-C. is supported by US National Institutes of Health grant K23-HL-080025, a Doris Duke Charitable Foundation Clinical Scientist Development Award, and a Burroughs Wellcome Fund Career Award for Medical Scientists. M.E. is funded by the Netherlands Heart Foundation (#2007B221). J.I.R. is supported by the Cedars-Sinai Board of Governors' Chair in Medical Genetics. The authors wish to thank the following people: G. Crawford and C. Guiducci (Broad Institute of Harvard and Massachusetts Institute of Technology) who completed the Sequenom-based technical validation genotyping of the Framingham Heart Study samples; P. Arp and M. Jhamai (Erasmus Medical Center) for Illumina array genotyping and Taqman-based technical validation genotyping of the Rotterdam Study samples; and Dr. M. Moorhouse, M. Verkerk and S. Bervoets (Erasmus Medical Center) for database management in the Rotterdam Study; and the study participants, the staff from the Rotterdam Study and the participating general practitioners and pharmacists. The QTGEN consortium would like to thank the QTSCD consortium for the opportunity to exchange top results pre-publication.

Author information

Author notes

1. Christopher Newton-Cheh, Mark Eijgelsheim, Kenneth M Rice and Paul I W de Bakker: These authors contributed equally to this work.
2. Thomas Lumley, Martin G Larson and Bruno H Ch Stricker: These authors jointly directed this work.

Authors and Affiliations

1. Center for Human Genetic Research, Cardiovascular Research Center, Massachusetts General Hospital, Boston, Massachusetts, USA
   Christopher Newton-Cheh & Peter A Noseworthy
2. Program in Medical and Population Genetics, Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA
   Christopher Newton-Cheh & Paul I W de Bakker
3. National Heart, Lung and Blood Institute's Framingham Heart Study, Framingham, Massachusetts, USA
   Christopher Newton-Cheh, Xiaoyan Yin, Christopher J O'Donnell & Martin G Larson
4. Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands
   Mark Eijgelsheim, Fernando Rivadeneira, Jacqueline C M Witteman, Albert Hofman, André G Uitterlinden & Bruno H Ch Stricker
5. Department of Biostatistics, University of Washington, Seattle, Washington, USA
   Kenneth M Rice & Thomas Lumley
6. Division of Genetics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA
   Paul I W de Bakker
7. Department of Mathematics and Statistics, Boston University, Boston, Massachusetts, USA
   Xiaoyan Yin & Martin G Larson
8. Department of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands
   Karol Estrada, Fernando Rivadeneira, André G Uitterlinden & Bruno H Ch Stricker
9. Cardiovascular Health Research Unit, University of Washington, Metropolitan Park East Tower, Seattle, Washington, USA
   Joshua C Bis, Kristin Marciante, Nona Sotoodehnia, Nicholas L Smith, Susan R Heckbert & Bruce M Psaty
10. Department of Medicine, University of Washington, Seattle, Washington, USA
    Joshua C Bis, Kristin Marciante & Bruce M Psaty
11. Division of Cardiology, Department of Medicine, University of Washington School of Medicine, Seattle, Washington, USA
    Nona Sotoodehnia
12. Department of Epidemiology, University of Washington, Seattle, Washington, USA
    Nicholas L Smith, Susan R Heckbert & Bruce M Psaty
13. Seattle Epidemiologic Research Center, Veterans Administration Office of Research and Development, Seattle, Washington, USA
    Nicholas L Smith
14. Medical Genetics Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA
    Jerome I Rotter
15. Department of Medical Informatics, Erasmus Medical Center, Rotterdam, The Netherlands
    Jan A Kors & Bruno H Ch Stricker
16. Netherlands Genomics Initiative-sponsored Netherlands Consortium for Healthy Aging, PO Box 2040, 3000 CA, Rotterdam, The Netherlands
    Jacqueline C M Witteman, Albert Hofman, André G Uitterlinden & Bruno H Ch Stricker
17. Center for Health Studies, Group Health, Seattle, Washington, USA
    Susan R Heckbert & Bruce M Psaty
18. National Heart, Lung and Blood Institute, Bethesda, Maryland, USA
    Christopher J O'Donnell
19. Cardiology Division, Massachusetts General Hospital, Boston, Massachusetts, USA
    Christopher J O'Donnell
20. Department of Health Services, University of Washington, Seattle, Washington, USA
    Bruce M Psaty
21. Inspectorate of Health Care, The Hague, The Netherlands
    Bruno H Ch Stricker

Authors

1. Christopher Newton-Cheh
   You can also search for this author inPubMed Google Scholar
2. Mark Eijgelsheim
   You can also search for this author inPubMed Google Scholar
3. Kenneth M Rice
   You can also search for this author inPubMed Google Scholar
4. Paul I W de Bakker
   You can also search for this author inPubMed Google Scholar
5. Xiaoyan Yin
   You can also search for this author inPubMed Google Scholar
6. Karol Estrada
   You can also search for this author inPubMed Google Scholar
7. Joshua C Bis
   You can also search for this author inPubMed Google Scholar
8. Kristin Marciante
   You can also search for this author inPubMed Google Scholar
9. Fernando Rivadeneira
   You can also search for this author inPubMed Google Scholar
10. Peter A Noseworthy
    You can also search for this author inPubMed Google Scholar
11. Nona Sotoodehnia
    You can also search for this author inPubMed Google Scholar
12. Nicholas L Smith
    You can also search for this author inPubMed Google Scholar
13. Jerome I Rotter
    You can also search for this author inPubMed Google Scholar
14. Jan A Kors
    You can also search for this author inPubMed Google Scholar
15. Jacqueline C M Witteman
    You can also search for this author inPubMed Google Scholar
16. Albert Hofman
    You can also search for this author inPubMed Google Scholar
17. Susan R Heckbert
    You can also search for this author inPubMed Google Scholar
18. Christopher J O'Donnell
    You can also search for this author inPubMed Google Scholar
19. André G Uitterlinden
    You can also search for this author inPubMed Google Scholar
20. Bruce M Psaty
    You can also search for this author inPubMed Google Scholar
21. Thomas Lumley
    You can also search for this author inPubMed Google Scholar
22. Martin G Larson
    You can also search for this author inPubMed Google Scholar
23. Bruno H Ch Stricker
    You can also search for this author inPubMed Google Scholar

Contributions

Framingham Heart Study: M.G.L., C.N.-C., P.A.N., C.J.O., X.Y.

Rotterdam Study: M.E., K.E., A.H., J.A.K., F.R., B.H.Ch.S., A.G.U., J.C.M.W.

Cardiovascular Health Study: J.C.B., S.R.H., T.L., K.M., C.N.-C., B.M.P., K.M.R., J.I.R., N.L.S., N.S.

Broad Institute of Harvard and Massachusetts Institute of Technology: P.I.W.dB., C.N.-C.

Design of QTGEN study: P.I.W.dB., M.E., M.G.L., T.L., C.N.-C., C.J.O., B.M.P., K.M.R., B.H.Ch.S. Genotyping: Affymetrix, C.N.-C., F.R., J.I.R., A.G.U. Statistical analysis and informatics: J.C.B., P.I.W.dB., M.E., K.E., T.L., K.M., C.N.-C., K.M.R., F.R., A.G.U., X.Y. Drafting of manuscript: C.N.-C. Critical revision of manuscript: J.C.B., P.I.W.dB., M.E., K.E., S.R.H., A.H., J.A.K., P.A.N., B.M.P., K.M.R., J.I.R., N.L.S., N.S., B.H.Ch.S., J.C.M.W.

Corresponding authors

Correspondence toChristopher Newton-Cheh or Bruno H Ch Stricker.

Supplementary information

Rights and permissions

About this article

Cite this article

Newton-Cheh, C., Eijgelsheim, M., Rice, K. et al. Common variants at ten loci influence QT interval duration in the QTGEN Study.Nat Genet 41, 399–406 (2009). https://doi.org/10.1038/ng.364

Download citation

• Received: 07 August 2008
• Accepted: 19 January 2009
• Published: 22 March 2009
• Issue Date: April 2009
• DOI: https://doi.org/10.1038/ng.364